{"page_content": "Appendix\n67  |  ENVIRONMENTAL, SOCIAL & GOVERNANCE REPORT 2021\nIntroduction COVID-19 Response Healthy People Healthy Society Healthy Planet A Healthy Amgen\nType Unit 2017 2018 2019 2020 2021\nTotal Revenue $ Millions $22,849 $23,747 $23,362 $25,424 $25,979\n          Product Sales $ Millions $21,795 $22,533 $22,204 $24,240 $24,297\nR&D Expenses $ Millions $3,562 $3,737 $4,116 $4,207 $4,819\nTotal Energy (i) 1,000 GJ 3,709 3,284 3,094 3,286 3,193\nTotal Carbon From Energy (i) 1,000 MT CO2Eq 278 263 249 243 155\nTotal Water Withdrawal (i) 2,000 CM 2,320 2,093 2,146 2,355 2,238\nTotal Routine Waste (i) MT 9,856 9,642 9,818 9,841 10,289\nEnvironmental Notices of Violation (NOVs) (ii) 1 NOV 1 3 2 1 3\nRecordable Incident Rate Injuries per 100 workers 0 .36 0 .42 0 .31 0 .31 0 .19\nStaff Lost Day Case Rate Injuries per 100 workers 0 .12 0 .14 0 .12 0 .08 0 .09\nStaff Fatalities People 1 0 0 1 0\nMotor Vehicle Safety Collisions per million miles NA NA 4 .40 3 .38 3 .09\nAmgen Employees* People  20,800  21,500 23,400  24,300 24,200\n% of Women in Total Workforce** People 51 52 52 52 52\n% of Women Management Level (iii)** People 44 45 46 47 49\n% of Women Executive Level (iv)** People 37 36 39 42 44\n% of Ethnic Minority in Workforce (U .S .) People 45 45 47 48 51\n% of Ethnic Minority Management Levels (U .S .) (iii) People 39 39 41 42 44\n% of Ethnic Minority Executive Level (U .S .) (iv) People 24 25 27 30 32\nValue of Medicines provided at no cost in low- and middle-income countries through Direct Relief (v) $ Millions $0 $69+ $0 $73+ $5\nValue of medicines provided at no cost to low-income patients in the United States through the \nAmgen Safety Net Foundation (v)$ Billions $0 .9+ $1 .2+ $1 .4+ $1 .5+ $2 .2+COMPANY PERFORMANCE DATA\n* As reported in Amgen\u2019s Form 10-K for the fiscal years \nended December 31, 2017 through 2021 .\n**  Data based on total headcount as reported in our Form \n10-K for the year ended December 31, 2021, modified \nto reflect active employee headcount which, among \nother things, excludes co-ops and interns  . Also excludes \nGensenta Pharmaceuticals and deCode Genetics  .DATA NOTES\ni)  Please see Responsibility/Environment on  \nwww  .amgen .com for an Independent Verification \nStatement forthis data .  Amgen has included data \nfrom 17 facilities covering energy and carbon, water \nand waste  . The facilities represent approximately  \n88 percent of Amgen\u2019s worldwide facility space \nbased on total square feet .  Included facilities are \nin Thousand Oaks, California, U .S .; West Greenwich, \nRhode Island, U .S .; Juncos, Puerto Rico, U .S .; Louisville, \nKentucky, U .S .; South San Francisco, California, U .S .; \nCambridge and Woburn, Massachusetts, U .S .; Burnaby, \nCanada; Breda, Netherlands; Dun Laoghaire, Ireland; \nUxbridge and Cambridge, United Kingdom; Sao \nPaulo, Brazil; Yenibosna and Sekerpinar, Turkey; \nTuas, Singapore; and Shanghai, China .  This includes \nleased buildings where we have operational control \nover building infrastructure, including utilities  .\nii)  Environmental notices of violation (NOVs) reported \nthat resulted from agency inspections  .\niiii)  Management: Senior managers and directors  .\niv)  Executive level: Executive directors and above  .\nv)  Value calculated at wholesale acquisition cost .APPENDIX", "metadata": {"source": "NASDAQ_AMGN_2021.pdf", "page": 66, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}